Search Results

You are looking at 1 - 10 of 126 items for :

  • Refine by Access: All x
Clear All
Full access

The Cancer Center Cessation Initiative Telehealth Working Group

Background The COVID-19 pandemic precipitated a rapid transformation in US healthcare delivery. Providers and systems abruptly shifted from in-person to virtual telehealth visits using digital video and audio tools. 1 Healthcare systems rapidly

Full access

Antoine Eskander, Qing Li, Jiayue Yu, Julie Hallet, Natalie G. Coburn, Anna Dare, Kelvin K.W. Chan, Simron Singh, Ambica Parmar, Craig C. Earle, Lauren Lapointe-Shaw, Monika K. Krzyzanowska, Timothy P. Hanna, Antonio Finelli, Alexander V. Louie, Nicole Look Hong, Jonathan C. Irish, Ian J. Witterick, Alyson Mahar, Christopher W. Noel, David R. Urbach, Daniel I. McIsaac, Danny Enepekides, and Rinku Sutradhar

place during the COVID-19 pandemic. 3 – 8 Disruption to healthcare access may negatively impact early detection of cancers and lead to a spurious decline in observed cancer incidence. Some countries observed a decrease in incidence rates during the

Full access

John R. Wingard

. 5. Morse SS . Pandemic influenza: studying the lessons of history . Proc Natl Acad Sci U S A 2007 ; 104 : 7313 – 7314 . 6. World Health Organization . Epidemic and pandemic alert and response (EPR) . Available at : http

Full access

Rui Fu, Rinku Sutradhar, Qing Li, Timothy P. Hanna, Kelvin K.W. Chan, Jonathan C. Irish, Natalie Coburn, Julie Hallet, Anna Dare, Simron Singh, Ambica Parmar, Craig C. Earle, Lauren Lapointe-Shaw, Monika K. Krzyzanowska, Antonio Finelli, Alexander V. Louie, Nicole J. Look Hong, Ian J. Witterick, Alyson Mahar, David Gomez, Daniel I. McIsaac, Danny Enepekides, David R. Urbach, and Antoine Eskander

diagnosis leads to delayed treatment, wherein even a 4-week delay can negatively impact survival. 3 In our previous publication in JNCCN , 1 we examined the fluctuation of cancer incidence volume over the first 6 months of the pandemic (March

Full access

Presenters: James E. Bachman, Kim Slusser, Thomas K. Varghese, Andrew Wagner, and moderated by Timothy Kubal

, and telemedicine was implemented for many patient visits. At Yale, during the first surge of the pandemic, there were more than 400 inpatients with COVID-19, explained Kim Slusser, RN, MSN, Vice President of Patient Affairs, Yale Cancer Center

Full access

Jessica Sugalski, Theresa Franco, Lawrence N. Shulman, Pelin Cinar, James Bachman, Jennie R. Crews, MiKaela Olsen, Alyssa Schatz, and Timothy Kubal

made its first appearance. 1 , 2 As the country shifts from crisis mode to learning to coexist with coronavirus, some silver linings to the pandemic are beginning to emerge. For centuries we have seen crises push industries to rapidly develop

Full access

Jessica Sugalski, Theresa Franco, Lawrence N. Shulman, Pelin Cinar, James Bachman, Jennie R. Crews, MiKaela Olsen, Alyssa Schatz, and Timothy Kubal

made its first appearance. 1 , 2 As the country shifts from crisis mode to learning to coexist with coronavirus, some silver linings to the pandemic are beginning to emerge. For centuries we have seen crises push industries to rapidly develop creative

Full access

Masumi Ueda, Renato Martins, Paul C. Hendrie, Terry McDonnell, Jennie R. Crews, Tracy L. Wong, Brittany McCreery, Barbara Jagels, Aaron Crane, David R. Byrd, Steven A. Pergam, Nancy E. Davidson, Catherine Liu, and F. Marc Stewart

, we are fortunate to provide care for patients with cancer in a resource-rich environment with state-of-the-art, life-saving treatments. However, the reality of diminishing supplies and hospital resources in the face of the COVID-19 pandemic is a

Full access

Elizabeth A. Griffiths, Laura M. Alwan, Kimo Bachiashvili, Anna Brown, Rita Cool, Peter Curtin, Mark B. Geyer, Ivana Gojo, Avyakta Kallam, Wajih Z. Kidwai, Dwight D. Kloth, Eric H. Kraut, Gary H. Lyman, Sudipto Mukherjee, Lia E. Perez, Rachel P. Rosovsky, Vivek Roy, Hope S. Rugo, Sumithira Vasu, Martha Wadleigh, Peter Westervelt, and Pamela S. Becker

exposed to SARS-CoV-2 infection, our panel convened a voluntary subcommittee to provide guidance for more optimal use of growth factors during the pandemic. Our goal from these suggestions is to reduce the risk of hematologic complications associated with

Full access

Elizabeth A. Griffiths, Laura M. Alwan, Kimo Bachiashvili, Anna Brown, Rita Cool, Peter Curtin, Mark B. Geyer, Ivana Gojo, Avyakta Kallam, Wajih Z. Kidwai, Dwight D. Kloth, Eric H. Kraut, Gary H. Lyman, Sudipto Mukherjee, Lia E. Perez, Rachel P. Rosovsky, Vivek Roy, Hope S. Rugo, Sumithira Vasu, Martha Wadleigh, Peter Westervelt, and Pamela S. Becker

voluntary subcommittee to provide guidance for more optimal use of growth factors during the pandemic. Our goal from these suggestions is to reduce the risk of hematologic complications associated with cancer chemotherapy and thereby to minimize exposure to